WGS Stock Analysis: Explosive Growth Potential in Rare Disease Genomics & AI Diagnostics
As of March 30, 2025, GeneDx Holdings Corp. (WGS) is gaining attention as a leading AI-powered genomic diagnostics company. With a current stock price of $92.2 and a strong focus on pediatric and rare disease genetic testing, WGS demonstrates robu…